1. Market Research
  2. > Cancer Industry

Leukemia Industry, January 2017 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Diagnostics, Cancer, Therapy, Blood Supply, Blood Disease, Pap Smear, Infectious Disease, Transplantation, Bone Marrow Transplant, Cancer Diagnostic, Lymphoma, Analgesic, Anti-Infective, Banking, Biopharmaceutical, Biopsy, Cell Therapy, Clinical Trial, Cloud Computing.


 
1-10 of about 300 reports for Leukemia

Purchase Reports From Reputable Market Research Publishers

 T-Cell Leukemia-Pipeline Insights, 2017

T-Cell Leukemia-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ T-Cell Leukemia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the T-Cell Leukemia. The DelveInsight’sReport ...

 Mast Cell Leukemia-Pipeline Insights, 2017

Mast Cell Leukemia-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Mast Cell Leukemia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Mast Cell Leukemia. The Delve ...

Chronic lymphocytic leukemia - Epidemiology Forecast To 2023

Chronic lymphocytic leukemia - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Chronic lymphocytic leukemia - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Chronic lymphocytic leukemia in seven major markets (US, France, Germany, ...

 Acute Promyelocytic Leukemia-Pipeline Insights, 2017

Acute Promyelocytic Leukemia-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Acute Promyelocytic Leukemia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Acute Promyelocytic ...

 B-Cell Chronic Lymphocytic Leukemia-Pipeline Insights, 2017

B-Cell Chronic Lymphocytic Leukemia-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ B-Cell Chronic Lymphocytic Leukemia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the B-Cell Chronic ...

 B-Cell Leukemia-Pipeline Insights, 2017

B-Cell Leukemia-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ B-Cell Leukemia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the B-Cell Leukemia. The DelveInsight’sReport ...

 Hairy Cell Leukemia-Pipeline Insights, 2017

Hairy Cell Leukemia-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Hairy Cell Leukemia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Hairy Cell Leukemia. The Del ...

 Relapsed Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights, 2017

Relapsed Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Relapsed Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Relapsed ...

 Relapsed/ Refractory Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights, 2017

Relapsed/ Refractory Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Relapsed/ Refractory Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around ...

 Refractory Leukemia-Pipeline Insights, 2017

Refractory Leukemia-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Refractory Leukemia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Refractory Leukemia. The Del ...

About 5800 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Leukemia Statistics in the US

  • January 2016
    147 pages
  • Leukemia  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.